Compound selection for development - is salt formation the ultimate answer? Experiences with an extended concept of the "100mg approach".
暂无分享,去创建一个
[1] S. Balbach,et al. Pharmaceutical evaluation of early development candidates "the 100 mg-approach". , 2004, International journal of pharmaceutics.
[2] J C Bradford,et al. Nephrotoxicity of pravadoline maleate (WIN 48098-6) in dogs: evidence of maleic acid-induced acute tubular necrosis. , 1993, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[3] R. Strickley,et al. Preformulation Salt Selection. Physical Property Comparisons of the Tris(hydroxymethyl)aminomethane (THAM) Salts of Four Analgesic/Antiinflammatory Agents with the Sodium Salts and the Free Acids , 1987, Pharmaceutical Research.
[4] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[5] Richard J. Bastin,et al. Salt Selection and Optimisation Procedures for Pharmaceutical New Chemical Entities , 2000 .
[6] Jochen Maas,et al. An integrated early formulation strategy--from hit evaluation to preclinical candidate profiling. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[7] Donald C. Monkhouse,et al. Review ArticlePharmaceutical Salts , 1977 .
[8] William Jones,et al. Occurrence of pharmaceutically acceptable anions and cations in the Cambridge Structural Database. , 2005, Journal of pharmaceutical sciences.
[9] Karen C. Thompson,et al. Discovery of a stable molecular complex of an API with HCl: a long journey to a conventional salt. , 2008, Journal of pharmaceutical sciences.
[10] C. Lipinski. Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.
[11] M. Bowker,et al. Preparation of Water-Soluble Compounds Through Salt Formation , 2008 .
[12] S. Venkatesh,et al. Role of the development scientist in compound lead selection and optimization. , 2000, Journal of pharmaceutical sciences.
[13] Jennifer B Dressman,et al. Trends in active pharmaceutical ingredient salt selection based on analysis of the Orange Book database. , 2007, Journal of medicinal chemistry.
[14] Filippos Kesisoglou,et al. Nanosizing--oral formulation development and biopharmaceutical evaluation. , 2007, Advanced drug delivery reviews.
[15] P. L. Gould,et al. Salt selection for basic drugs , 1986 .
[16] Xue-Qing Chen,et al. Discovery pharmaceutics—Challenges and opportunities , 2006, The AAPS Journal.
[17] Colin W Pouton,et al. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[18] G. Stephenson,et al. Physical stability of salts of weak bases in the solid-state. , 2011, Journal of pharmaceutical sciences.
[19] M. Peterson,et al. Salt Screening and Selection , 2010, Burger's Medicinal Chemistry and Drug Discovery.
[20] Elaine Merisko-Liversidge,et al. Nanosizing: a formulation approach for poorly-water-soluble compounds. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[21] Christopher T. Walsh,et al. Drugs as materials: valuing physical form in drug discovery , 2004, Nature Reviews Drug Discovery.
[22] M. S. Ku,et al. A biopharmaceutical classification-based Right-First-Time formulation approach to reduce human pharmacokinetic variability and project cycle time from First-In-Human to clinical Proof-Of-Concept , 2012, Pharmaceutical development and technology.
[23] W. Tong,et al. In situ salt screening--a useful technique for discovery support and preformulation studies. , 1998, Pharmaceutical development and technology.
[24] V. Saxena,et al. Developability assessment in pharmaceutical industry: An integrated group approach for selecting developable candidates. , 2009, Journal of pharmaceutical sciences.
[25] D. Hauss. Oral lipid-based formulations. , 2007, Advanced drug delivery reviews.
[26] W. Tong,et al. Impact of solid state properties on developability assessment of drug candidates. , 2004, Advanced drug delivery reviews.